S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride
Clinical trial NCT01416688 · COMPLETED
Trial details
- NCT number
- NCT01416688
- Sponsor
- SWOG Cancer Research Network
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-11-15
- Primary completion
- 2018-05-01
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.